When a fast-moving biotech with a broad oncology pipeline faced urgent forecasting challenges ahead of a pivotal Phase III launch, they turned to J+D Forecasting to overhaul their approach.
What followed was a complete transformation – from fragmented, finance-led models to a scalable, best-practice forecasting framework built for strategic decision-making and long-term success.
In this case study, you’ll learn how we enabled the company to:
- Adopt a robust patient-flow methodology using Onco+ to accelerate model development
- Upskill internal teams with hands-on support and tailored coaching
- Build a scalable, future-ready platform to prioritize assets and support commercialization
Download the full case study
